AIDS WEEKLY Plus - December 2004Important note: Information in this article was accurate in December 2004. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

DonateNow
Print this Article

HIV/AIDS-Associated Lipodystrophy: Interleukin-18 linked to HIV-associated lipodystrophy

AIDSWEEKLY Plus; Monday, December 27, 2004
Staff Medical Writers


NewsRx -- Interleukin-18 is linked to HIV-associated lipodystrophy.

According to published research from Denmark, "IL-18 is an inducer of apoptosis/tissue injury. IL-18 messenger RNA expression was examined in adipose tissue (AT) obtained from HIV patients with lipodystrophy, without lipodystrophy and healthy controls."

"IL-18 mRNA was expressed in AT at increased levels in lipodystrophy-positive compared with lipodystrophy-negative patients and healthy controls. Higher levels of IL-18 mRNA were found in femoral-gluteal AT compared with abdominal AT, and correlated with limb fat loss," reported B. Lindegaard and colleagues.

"These findings suggest that IL-18 is linked to HIV-associated lipodystrophy," the authors concluded.

Lindegaard and colleagues published their findings in AIDS (Adipose tissue expression of IL-18 and HIV associated lipodystrophy. AIDS. 2004 Sep 24;18(14):1956-8.

Additional information can be obtained by contacting B. Lindegaard, Rigshosp, Copenhagen Muscle Research Center, Copenhagen, Denmark.

The publisher of the journal AIDS can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St., Philadelphia, PA 19106-3621, USA.

The information in this article comes under the major subject areas of HIV/AIDS, Lipodystrophy and Interleukin-18.

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Lindegaard B, Hansen AB, Pilegaard H "Adipose tissue expression of IL-18 and HIV-associated lipodystrophy", AIDS. 2004 Sep 24;18(14):1956-8.

PubMED Related articles Search

041227
AW041212


Copyright © 2004 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.